We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$7.68B
AUM Growth
+$3.22B
(+72%)
Cap. Flow
+$3.51B
Cap. Flow
% of AUM
45.78%
Top 10 Holdings %
Top 10 Hldgs %
77.12%
Holding
65
New
7
Increased
1
Reduced
6
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEUE
NeueHealth
NEUE
|
+$3.74B |
| 2 |
Monte Rosa Therapeutics
GLUE
|
+$157M |
| 3 |
BILL Holdings
BILL
|
+$87.9M |
| 4 |
CVRx
CVRX
|
+$66.4M |
| 5 |
OKUR
OnKure Therapeutics
OKUR
|
+$53.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coursera
COUR
|
+$196M |
| 2 |
DM
Desktop Metal, Inc.
DM
|
+$118M |
| 3 |
Sprout Social
SPT
|
+$89.2M |
| 4 |
EAR
Eargo, Inc. Common Stock
EAR
|
+$83.8M |
| 5 |
Opendoor
OPEN
|
+$59.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 79.17% |
| 2 | Consumer Staples | 8.56% |
| 3 | Technology | 5.15% |
| 4 | Industrials | 3.37% |
| 5 | Financials | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEUE
1
DELISTED
NeueHealth
NEUE
| $3.74B | 48.77% |
+2,727,652
| New | +$3.74B |
|
|
2
Coursera
COUR
$1.72B
| $657M | 8.56% |
16,603,063
-4,553,828
| -22% | -$196M |
|
3
Cloudflare
NET
$94.5B
| $292M | 3.81% |
2,763,583
| – | – |
|
4
CRISPR Therapeutics
CRSP
$4.64B
| $257M | 3.35% |
1,590,002
| – | – |
|
|
DM
5
DELISTED
Desktop Metal, Inc.
DM
| $223M | 2.91% |
1,941,063
-900,546
| -32% | -$118M |
|
|
ALLK
6
DELISTED
Allakos
ALLK
| $185M | 2.41% |
2,164,704
| – | – |
|
|
EAR
7
DELISTED
Eargo, Inc. Common Stock
EAR
| $180M | 2.35% |
226,034
-100,013
| -31% | -$83.8M |
|
|
8
Monte Rosa Therapeutics
GLUE
$1.85B
| $175M | 2.28% |
+7,703,205
| New | +$157M |
|
9
Ardelyx
ARDX
$1.24B
| $103M | 1.35% |
13,633,582
| – | – |
|
|
10
BILL Holdings
BILL
$4.7B
| $103M | 1.34% |
+560,774
| New | +$87.9M |
|
|
OYST
11
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $102M | 1.33% |
5,925,287
| – | – |
|
12
Rhythm Pharmaceuticals
RYTM
$7.4B
| $96.2M | 1.25% |
4,912,306
| – | – |
|
13
Nkarta
NKTX
$157M
| $92.1M | 1.2% |
2,904,974
| – | – |
|
|
MILE
14
DELISTED
Metromile, Inc. Common Stock
MILE
| $85.9M | 1.12% |
9,384,295
| – | – |
|
|
ADAP
15
DELISTED
Adaptimmune Therapeutics
ADAP
| $72.8M | 0.95% |
17,082,611
| – | – |
|
16
Mirum Pharmaceuticals
MIRM
$6.72B
| $72.4M | 0.94% |
4,187,801
| – | – |
|
17
Aurinia Pharmaceuticals
AUPH
$1.92B
| $67M | 0.87% |
5,172,683
| – | – |
|
|
18
CVRx
CVRX
$132M
| $66.4M | 0.86% |
+2,370,858
| New | +$66.4M |
|
|
19
Opendoor
OPEN
$3.73B
| $59.1M | 0.77% |
3,444,385
-3,444,381
| -50% | -$59.2M |
|
20
Annexon
ANNX
$786M
| $56.2M | 0.73% |
2,497,661
| – | – |
|
|
TRIL
21
DELISTED
Trillium Therapeutics Inc.
TRIL
| $55.6M | 0.72% |
5,736,363
| – | – |
|
|
AKUS
22
DELISTED
Akouos Inc
AKUS
| $53.9M | 0.7% |
4,298,488
| – | – |
|
23
VistaGen Therapeutics
VTGN
$9.7M
| $51.4M | 0.67% |
543,420
| – | – |
|
|
CSPR
24
DELISTED
Casper Sleep Inc.
CSPR
| $51.3M | 0.67% |
6,226,130
| – | – |
|
|
OKUR
25
OnKure Therapeutics
OKUR
$159M
| $44.7M | 0.58% |
+478,692
| New | +$53.4M |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q2 2021 Portfolio in Review
As of Q2 2021, NEA Management Company held 65 positions worth $7.68B, up 72% from $4.46B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
NEA Management Company deployed $3.51B of net new capital in Q2 2021, opening 7 new positions and adding to 1 existing holding. Its largest new stake was NeueHealth: 2,727,652 shares worth $3.74B.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 53% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Coursera, an estimated $196M trimmed.
- NEA Management Company's largest Q2 2021 buy was NeueHealth: 2,727,652 shares worth $3.74B.
- NEA Management Company added most to Satsuma Pharmaceuticals, Inc. Common Stock in Q2 2021, an estimated $783K increase.
- NEA Management Company's biggest Q2 2021 reduction was Coursera, cutting an estimated $196M.
- NEA Management Company fully exited Sprout Social in Q2 2021, selling an estimated $89.2M.
- NEA Management Company's ten largest holdings make up 77% of its $7.68B portfolio in Q2 2021.
- NEA Management Company opened 7 new positions and closed 2 in Q2 2021.
- NEA Management Company's portfolio value rose 72% quarter-over-quarter to $7.68B.
Based on NEA Management Company's 13F filing for Q2 2021, filed 2 Aug 2021.